Maplight Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Maplight Therapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Maplight Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Maplight Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Maplight Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $321k | 18k | 17.57 |